Twenty-two days after injection, we found a remarkable tumor volume decrease in XIAP-shRNA mice compared with the control shRNA mice (651.2±170.5 mm3 vs. 1,894.6±157.1 mm3, P< 0.01). The gene discussed is XIAP; the disease is neoplasm.